rs2453051
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_024408.4(NOTCH2):c.2027-1718T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.167 in 152,082 control chromosomes in the GnomAD database, including 2,895 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.17 ( 2895 hom., cov: 32)
Consequence
NOTCH2
NM_024408.4 intron
NM_024408.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.239
Publications
12 publications found
Genes affected
NOTCH2 (HGNC:7882): (notch receptor 2) This gene encodes a member of the Notch family. Members of this Type 1 transmembrane protein family share structural characteristics including an extracellular domain consisting of multiple epidermal growth factor-like (EGF) repeats, and an intracellular domain consisting of multiple, different domain types. Notch family members play a role in a variety of developmental processes by controlling cell fate decisions. The Notch signaling network is an evolutionarily conserved intercellular signaling pathway which regulates interactions between physically adjacent cells. In Drosophilia, notch interaction with its cell-bound ligands (delta, serrate) establishes an intercellular signaling pathway that plays a key role in development. Homologues of the notch-ligands have also been identified in human, but precise interactions between these ligands and the human notch homologues remain to be determined. This protein is cleaved in the trans-Golgi network, and presented on the cell surface as a heterodimer. This protein functions as a receptor for membrane bound ligands, and may play a role in vascular, renal and hepatic development. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2011]
NOTCH2 Gene-Disease associations (from GenCC):
- acroosteolysis dominant typeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)
- Alagille syndrome due to a NOTCH2 point mutationInheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- Alagille syndromeInheritance: AD Classification: MODERATE Submitted by: Illumina
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.99).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.318 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| NOTCH2 | ENST00000256646.7 | c.2027-1718T>G | intron_variant | Intron 12 of 33 | 1 | NM_024408.4 | ENSP00000256646.2 | |||
| NOTCH2 | ENST00000479412.2 | n.2165-1718T>G | intron_variant | Intron 11 of 13 | 1 | |||||
| NOTCH2 | ENST00000640021.1 | n.*1151-1718T>G | intron_variant | Intron 9 of 11 | 5 | ENSP00000492223.1 |
Frequencies
GnomAD3 genomes AF: 0.167 AC: 25328AN: 151964Hom.: 2884 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
25328
AN:
151964
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.167 AC: 25360AN: 152082Hom.: 2895 Cov.: 32 AF XY: 0.167 AC XY: 12385AN XY: 74356 show subpopulations
GnomAD4 genome
AF:
AC:
25360
AN:
152082
Hom.:
Cov.:
32
AF XY:
AC XY:
12385
AN XY:
74356
show subpopulations
African (AFR)
AF:
AC:
13347
AN:
41392
American (AMR)
AF:
AC:
1631
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
AC:
289
AN:
3470
East Asian (EAS)
AF:
AC:
164
AN:
5190
South Asian (SAS)
AF:
AC:
915
AN:
4830
European-Finnish (FIN)
AF:
AC:
1410
AN:
10580
Middle Eastern (MID)
AF:
AC:
24
AN:
294
European-Non Finnish (NFE)
AF:
AC:
7196
AN:
68002
Other (OTH)
AF:
AC:
330
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1016
2032
3047
4063
5079
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
258
516
774
1032
1290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
571
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.